Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.
Published August 13, 2014 · Recall initiated: June 2, 2014
Summary
FDA records drug Class I recall D-1512-2014, published August 13, 2014 and initiated June 2, 2014. Recalling firm: Alexion Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 96,506 vials; Lot: Lots: 10002-1, 00006-1, Exp 08/14; 10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
What to do
Voluntary: Firm initiated · Press Release
Get an email if SOLIRIS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SOLIRIS
- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Distributor
- Nationwide and Puerto Rico
- UPC
- 325682001016
- Lot
- Lots: 10002-1, 00006-1, Exp 08/14; 10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-294-88) and b) 500-count bottlesAugust 13, 2014
- FDAbuPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by:August 13, 2014
- FDACephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottlesAugust 13, 2014
- FDARisperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc.,August 13, 2014
- FDAPatient Data Manager 2.0 (Content manager 2.0, Patient Browser 4.0, DICOM Viewer 2.0) Brainlab DigitalAugust 6, 2014
- FDASoliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mLFebruary 5, 2014
Questions about this recall
Was Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6. recalled?
Yes. FDA published recall D-1512-2014 on August 13, 2014. Reported hazard: Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SOLIRIS. UPC: 325682001016.